Concordance Among Four Commercially Available, Validated Programmed Cell Death Ligand-1 Assays in Urothelial Carcinoma
Diagnostic Pathology - United Kingdom
doi 10.1186/s13000-019-0873-6
Full Text
Open PDFAbstract
Available in full text
Date
September 2, 2019
Authors
Publisher
Springer Science and Business Media LLC